Immunic Inc. (IMUX) Reports FY21 EPS of ($3.93)

Immunic Inc. (NASDAQ: IMUX) reported FY21 EPS of ($3.93). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Cerebras Q1 EPS miss sends shares down 9% after-hours